Until now, neither of these two popular drugs have been covered by Medicare for weight loss and they've only rarely been covered by Medicaid. They've often cost consumers more than $1,000 per month and some a lot more than that. Americans have been spending as much as 520% more for Zepbound and 1,400% more for WeGovy than patients in Europe. Think of that. 1,400% more than a patient year for the exact same box. And that ends starting today. The other countries are not happy with us. (04:27–04:39)
CLAIM
Asserts that Americans pay significantly more for certain drugs compared to Europeans.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
